Takeda Pharmaceutical CEO Christophe Weber highlighted the importance of gaining a strong foothold in the world’s largest pharma market at…
ORGANIZATION
Bayer Yakuhin Chief Prinz Named Vice Chairman of EFPIA Japan
Bayer Yakuhin President Heike Prinz was appointed vice chairman of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan, effective September 1. A German native, Ms Prinz is taking over the role from GlaxoSmithKline’s Philippe Fauchet, who left the…
To read the full story
ORGANIZATION
- 9 EFPIA Companies Reviewed Headcount Planning after Drug Pricing Overhaul: Survey
December 5, 2018
- JPMA Chief Warns against Japan Govt’s Short-Sighted Budgeting, Calls for Longer-Term View on Innovation
November 26, 2018
- 8 Infectious Disease-Related Societies Launch New Organization to Combat Drug-Resistance Problem
November 12, 2018
- 7 EFPIA Companies Revised R&D Strategies after April Pricing Overhaul: Survey
November 9, 2018
- Wrong Policies Could Drive Investments Out of Japan amid China’s Rise, PhRMA Int’l Advocacy Chief Warns
November 6, 2018
While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…
Daiichi Sankyo and GlaxoSmithKline recently announced that they have agreed to dissolve their joint venture company, Japan Vaccine. The failure of this model of joint venture between a major Japanese and foreign drug maker in just six years is disappointing.Over…
To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…